J. Moran-Gilad, E. Kaliner, M. Gdalevich, I. Grotto

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

D. Holt, F. Bouder, C. Elemuwa, G. Gaedicke, A. Khamesipour, B

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Education in infection control: A need for European certification

Refugee crisis and re-emergence of forgotten infections in Europe

D. Holt, F. Bouder, C. Elemuwa, G. Gaedicke, A. Khamesipour, B

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

The importance of enterovirus surveillance in a Post-polio world

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Training for the infectious diseases speciality in Norway

Isospora belli Clinical Microbiology and Infection

B. Gordts Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Can we control all-cause meningococcal disease in Europe?

World Health Organization SAVE LIVES: Clean Your Hands global campaign—‘Fight antibiotic resistance—it's in your hands' E. Tartari, M. Abbas, D. Pires,

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Previously unknown species of Aspergillus

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Vaccinations against respiratory tract infections at Hajj

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment J.C. Clegg Clinical Microbiology and Infection

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

E. Tartari, P. Muthukumaran, A. Peters, B. Allegranzi, D. Pittet

C. Socolovschi, D. Raoult, P. Parola

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Public health response to the silent reintroduction of wild poliovirus to Israel, 2013– 2014 J. Moran-Gilad, E. Kaliner, M. Gdalevich, I. Grotto Clinical Microbiology and Infection Volume 22, Pages S140-S145 (December 2016) DOI: 10.1016/j.cmi.2016.06.018 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 The response cycle to polio incident. The risk assessment phase informed both risk management and risk communication, which also influenced each other. The entire process is iterative as feedback from risk management and risk communication is used to fine tune the risk assessment during the course of the response. Clinical Microbiology and Infection 2016 22, S140-S145DOI: (10.1016/j.cmi.2016.06.018) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 The slogan for the supplemental bivalent oral polio vaccine campaign, Israel 2013. Clinical Microbiology and Infection 2016 22, S140-S145DOI: (10.1016/j.cmi.2016.06.018) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions